ProFunds Biotechnology UltraSector Inv
Profunds 3435 Stelzler Rd Columbus, OH 43219
Map
Phone: 888-776-3637
| Category: | Health | | Fund Family: | ProFunds | | Net Assets: | 10.15M | | Year-to-Date Return: | 1.15% | | Yield: | 0.00% | | Morningstar Rating: |  | | Fund Inception Date: | 19-Jun-00 |
|
Howard S. Rubin
Lead Manager since
01-Dec-09 | | | Rubin has been a senior portfolio manager with ProFund Advisors since November 2004, except for the period from May 13, 2005 to July 17, 2005, during which he was self-employed. He was a portfolio manager from April 2000 to November 2004. Rubin holds the Chartered Financial Analyst designation. |
| Min Initial Investment: | $15,000 | | Min Initial Investment, IRA: | $15,000 | | Min Initial Investment, AIP: | $15,000 | | Min Subsequent Investment: | $100 | | Min Subsequent Investment, IRA: | $100 | | Min Subsequent Investment, AIP: | $100 |
|
| |
| The investment seeks daily investment results that correspond to 150% of the daily performance of the Dow Jones U.S. Biotechnology index. The fund normally commits at least 80% of assets to equity securities contained in the index and/or financial instruments that have similar economic characteristics. It employs leveraged investment techniques and may use sampling techniques in seeking its investment objective. The fund invests assets which are not invested in equity securities or financial instruments in debt instruments or money market instruments. It is nondiversified. |
| Last Dividend
| YFT_NOT_APPLICABLE_ABBREVIATION | | Last Cap Gain
| YFT_NOT_APPLICABLE_ABBREVIATION | | Annual Holdings Turnover
| 519.00% | | Average for Category:
| 134.89% |
|
| Expense | BIPIX | Category
Avg | | Total Expense Ratio: | %
| 1.91% | | Max 12b1 Fee: | %
| N/A | | Max Front End Sales Load: | %
| 5.35% | | Max Deferred Sales Load: | %
| 2.88% | | 3 Yr Expense Projection*: |
$ YFT_NOT_APPLICABLE_ABBREVIATION | $719 | | 5 Yr Expense Projection*: |
$ YFT_NOT_APPLICABLE_ABBREVIATION | $1,076 | | 10 Yr Expense Projection*: |
$ YFT_NOT_APPLICABLE_ABBREVIATION | $2,105 |
|
|
0.20% Nasdaq 
Profile
